Vixiar Medical’s Indicor™ platform turns a rapid point-of-care test into an accurate, objective measure of hemodynamic congestion, intercepting worsening heart failure long before patients end up back in the ER. Every...
Commercial Executive Brings Over 20 Years of Strategic Healthcare and Sales Leadership to Accelerate Growth and Scale Market Access for Non-Invasive Cardiac Analysis Platform
The VIC Tech investment model sources promising life science innovations directly from top universities globally, providing early-stage capital to launch startups, advance core technologies, and drive them toward...
Flourish Biologics has named David J. Leffell, MD, as Chief Executive Officer. Dr. Leffell will guide the company through its next phase of growth following its recent evolution from BiologicsMD into a company sharply...
Enhance Health, a healthcare platform delivering at-home monitoring and care workflows for liver disease, chronic kidney disease, and urea cycle disorders, announced today the appointment of Dave Firdaus to its...
Novel closed-loop platform introduces objective verification to one of healthcare’s most persistent patient safety challenges. Restara Medical today announced its official launch as a medical technology company...
In the first half of 2026, VIC Tech drove widespread momentum across its portfolio, highlighted by numerous successes in financing, regulatory wins, and commercial traction. Click Here to download the Mid-Year Update or...
BiologicsMD, Inc. has evolved into Flourish Biologics, a transformation that sharpens the company's focus on its lead regenerative dermatology franchise after years developing a broader pipeline spanning hair loss, bone...
Over the previous three articles in this series, we've looked at the life science innovation ecosystem from different angles: the macro view of how it's structured [An Ecosystem Roadmap], the role of patient need in...
i-Seq Biotechnology, a life science company focused on advancing novel, broad-spectrum vaccines and therapeutics against infectious disease pathogens, announced today that it has signed a Stage I support agreement with...
FEATURED RESOURCES
